| Overview |
| bsm-90312r-50µL |
| Integrin β1/CD29 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human integrin beta-1/CD29 |
| 650-700/798 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 3688 |
| P05556 |
| GPIIA; MSK12; CD29; FNRB; MDF2; Integrin Beta 1 (Fibronectin Receptor Beta Polypeptide Antigen CD29 Includes MDF2 MSK12); Glycoprotein IIa; Integrin Beta-1; Very Late Activation Protein Beta Polypeptide; Fibronectin Receptor Subunit Beta; Integrin VLA-4 Beta Subunit; VLA-4 Subunit Beta; Integrin Beta 1; CD29 Antigen; VLA-BETA; VLAB |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |